dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 22. november 2019
Viit
1.4-2/2844-1
Registreeritud
22. november 2019
Dokumendi liik
Sissetulev kiri
Adressaat
P. I. F.
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2019
Vastutaja
Liisa Lents (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
22. detsember 2019

Failid

  • 📎1. 2019-11-18 Open Letter Micreos to MEPs.pdf235 KB
  • 📎2. 2019-11-18 English translation Micreos letter to Dutch Ministry of Health.pdf121 KB
  • 📎3. 2019-11-08 Letter of DG Sante Director Bernard Van Goethem re absence of authorization Listex on food of animal origin.pdf181 KB
  • 📎E-kiri.pdf412 KB
  • 📎Estonia.pdf104 KB

Sisu (failidest)

OPEN LETTER TO THE EUROPEAN PARLIAMENT ON THE CASE OF A SERIES OF LETHAL OUTBREAKS OF LISTERIA IN THE EU THAT CAN BE PREVENTED IF DG SANTE FOLLOWS A CALL TO ESTABLISH A NEW PHAGE REGULATION The Hague, November 18th, 2019 Dear Member of the European Parliament, Over the past 2 months outbreaks of the deadly bacterium Listeria on food occurred in Spain, Germany and The Netherlands. The resulting disease listeriosis killed and seriously debilitated around 1,000 persons, including several miscarriages. Despite the strict EU Regulations on hygiene, Listeria contamination of especially Ready-To-Eat (RTE) food is very difficult to combat, due to the resilience of the bacterium and the fact that it is naturally present in our environment. There is, however, a product that can reduce the number of listeriosis victims considerably: the phage-containing product ListexTM P100, produced by the company Micreos. According to independent experts, Listex, when used on RTE food, is able to prevent up to 74% of listeriosis cases. This safe and natural phage specifically kills only Listeria bacteria and has no effect on other types of bacteria. Consequently, its cannot be used to cover up a lack of hygiene by food processors. Nevertheless, the European Commission’s DG SANTE (responsible for public health) has in the past 12 years not been able to appropriately regulate Listex. This is despite the fact that the European Food Safety Authority has established in 2016 that Listex P100 is absolutely safe and effective. This is despite the fact that since 2006 Listex has been approved and safely used as a processing aid in major markets around the world, including the USA, Canada, Australia and Switzerland. Despite protests from the European Parliament, DG SANTE has cast a cloud of uncertainty over a life-saving product. Since 2006, Micreos has endeavoured to get confirmation of the use of Listex as a ‘non-decontaminating processing aid’ on animal-derived RTE food. Against expert advice, DG SANTE determined that this product should be regarded as a ‘decontaminant’ and therefore needed an authorisation under EU Regulation 853/2004. Even though top phage experts explained that Listex can be used only to prevent the outgrowth of Listeria on RTE food and not to decontaminate it, DG SANTE forced Micreos to start an authorisation of Listex as a ‘decontaminant’. Why was this wrong? Because Listex is used during production of RTE food that contains far less Listeria than the legally allowed number of 100 Colony Forming Units per gram final RTE food. This food is not ‘contaminated’ and thus cannot be de-contaminated either. This may have been among the reasons why EU Member States questioned DG SANTE’s choice of authorisation procedure. Because DG SANTE ‘was too busy’ with other dossiers, the civil servants subsequently decided to simply stop the procedure and then started to actively and inappropriately imply that use of Listex was illegal, exposing 1 European citizens to new and deadly listeria outbreaks - which indeed materialised since, despite DG SANTE’s claims this would not happen. As advised by a new Director General, Micreos challenged DG SANTE’s policies and actions before the European Union Court of Justice (EUCJ). DG SANTEs written ‘’advice” of 17th June 2019 – before the new outbreaks – explicitly included that DG SANTE did not take a decision on the legal classification of the use of Listex on RTE food of animal origin, but merely interpreted Regulation 853/2004. It seems DG SANTE took this position to avoid that the EUCJ would apply Interim Measures potentially leading to serious compensation claims by (relatives of) Listeria victims as well as Micreos to the European Commission. Indeed, the Court Order does not apply Interim Measures, but it argues that DG SANTE did not take any decision regarding Listex as it only aborted its own decontamination authorization procedure under regulation 853/2004. Furthermore, the Court Order refers to the ‘non-decontaminating’ function of Listex, while establishing that the absence of a Commission decision restores the position of the use of Listex as a non-decontaminating processing aid before DG SANTE started its failing decontamination authorization route. The Court proceedings are ongoing and a decision by the EUCJ is expected in one year and half – a very long time during which many more European citizens will fall victim to Listeria outbreaks. Nevertheless, and apparently at the invite of one Member State, DG SANTE tried to once again block the marketing of Listex – without DG SANTE haven taken any decision! How can a mere interpretation of the DG SANTE be enforced? In its letter of 8th November 2019 DG SANTE does not react to lethal outbreaks. It shows no empathy with the victims and their families. Instead, in this non-public letter to the Chief Veterinarians in all EU Member States, DG SANTE enquires whether Listex is used and implies that such use would be illegal (please see the DG SANTE letter attached; a legal rebuttal of this letter is attached as well). In this letter, the European Commission suggests that water should be used to prevent bacterial contamination. This is scientific nonsense, as water actually supports bacterial growth. Moreover, washing RTE products like cheese and sausages with water is equally nonsensical. Last but not least, DG SANTE explicitly states that it was Micreos which requested the use of Listex on animal-derived RTE food to be regulated as a decontaminating processing aid. Again, this misleads the readers: DG SANTE forced Micreos to take this incorrect regulatory route. To the total astonishment of Micreos and most if not all scientific and regulatory experts, after 12 years, the European Commission not only neglected its role as regulator but has started to harass and discredit Micreos and Listex. The persistence of DG SANTE to not immediately address the case of Listex totally ignores the present risks of loss of (unborn) life and lifelong serious health problems and seems to protect rather its own position than public health and the European Union’s top priorities including innovation and the support to Small and Medium Sized Enterprises, such as Micreos and the high priority to develop alternatives to antibiotics in the face of the health threat of antibiotic resistance. Indeed, on 15 November 2019 the European Court of Auditors’ report on Antimicrobial Resistance mentions that in the EU One Health Action Plan on AMR, the Commission set the objective to support SMEs in their research and development efforts. The role of SME’s in the discovery of 2 antimicrobials is increasing, particularly given the withdrawal of large pharmaceutical companies from such research. However, only a mere 5% of funding from the DG SANTE’s ND4BB programme of 357million Euro had been used for SMEs. There seems to be a pattern. And it is not shared by other DGs of the European Commission: In 2019 DG RTD (Research) awarded to Micreos the highest possible grant under its Horizon 2020 program to accelerate the availability of Micreos’ targeted antibacterial products, set to replace antibiotics. According to the jury representing the European Commission this technology has a high chance of success to improve the social wellbeing and global competitiveness of the EU and its citizens. Obviously, the positions and acts of DG SANTE towards Listex are a far cry from all of this. In the recent past, key Members of the European Parliament have already called on DG SANTE to develop the earliest possible framework for a new phage regulation while considering the use of Listex as a non-decontaminating processing aid in the meantime. As in other cases involving SMEs, DG SANTE turned down this best way out. Threatened in our existence, after heavily investing in effectively combating listeriosis in a spirit of private and public interest altogether, we must now call on the European Parliament to immediately take steps towards the creation of a new phage regulation while considering the use of Listex as a safe and effective non- decontaminating processing aid on RTE animal-derived food. As a Member of the European Parliament, the only EU institution with democratic legitimation, you can help save human lives unnecessarily jeopardised by DG SANTE’s 12 year-long bureaucratic approach. Please have the Commission publicly explain why it prefers to protect its previous erroneous decisions above protecting public health and food safety. As many other innovative SMEs, Micreos cannot survive without your support and neither can those exposed to an ever-growing listeria threat. I am entirely at your disposal for consultation and information and thank you in advance for your highly appreciated attention and support. Yours sincerely, Mark Offerhaus CEO Attachments: - Letter of DG SANTE to Chief Veterinarian Officers, 8 November 2019 - Mail of Micreos in response to DG SANTE letter (English translation), 18 November 2019 3 Ref. Ares(2019)6915736 - 08/11/2019 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Crisis management in food, animals and plants The Director Brussels, S ANTE.DDG2.G4/ACG(2019)5740164 Subject: Absence of authorisation at EU level of Listex P100 for use in food of animal origin. Dear colleagues, At the meeting of the food hygiene working group on 29 April 2019, request was made to the Commission to clarify the status of the product Listex™ PI00 as decontaminant in ready-to-eat foods of animal origin contaminated with Listeria. The Member States raised the fact that this product was advertised to business operators producing food of animal origin despite not being allowed on the market. Regulation (EC) No 853/2004 laying down specific hygiene rules for food of animal origin 1 forbids the use of any substance other than potable water for the decontamination of food of animal origin, unless expressly allowed. Article 3(2) of that Regulation stipulates: "Food business operators shall not use any substance other than potable water— or, when Regulation (EC) No 852/2004 or this Regulation permits its use, clean water — to remove surface contamination from products of animal origin, unless use of the substance has been approved by the Commission”. The authorisation of substances for decontamination is thus done by derogation from the hygiene rule established in Regulation (EC) No 853/2004 . In 2015 Micreos Food Safety submitted a request for approval of Listex™ PI00, a phage-based product, for use against the contamination with Listeria of ready-to-eat food, on the basis of Article 3(2) of Regulation (EC) No 853/2004. The request was processed by the Commission, and in 2016 the EFSA delivered an opinion "Evaluation of the safety and efficacy of ListexTMPlOO for reduction of pathogens on different ready- to-eat (RTE) food products." In 2017 discussions on this issue took place both in the working group and in the Standing Committee on Plants, Animals, Food and Feed. From the discussions, it became clear that there was an opposition against the required approval of Listex™ PI00. In that regard, by letter dated 19 February 2018, the Commission informed Micreos Food Safety of its decision that it did not intend to pursue the evaluation of the application. 1 Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific hygiene rules for food of animal origin (OJ L139 30.4.2004 p. 55) Chief Veterinary Officers of the Member States Commission européerme/Europese Commissie, 1049 Bruxelles/Bmssel, BELGIQUE/BELGIË - Tel. +32 22991111 Office: B232 03/003 - Tel. direct line +32 229 93338 With regard to the claim that the product should be considered as a processing aid, falling outside Regulation (EC) No 853/2004, it should be noted that processing aids are defined in Regulation (EC) No 1333/2008 on food additives2. However, Listex™ PI00 aims at reducing the Listeria contamination in ready-to-eat food of animal origin. It therefore falls under the scope of Article 3(2) of Regulation (EC) No 853/2004. Therefore, a possible qualification as a processing aid for the purpose of decontamination would not remove the prevailing authorisation obligation under Regulation (EC) No 853/2004. In August 2019, Micreos made an application to the EU General Court for annulment of the letters of the Director General for SANTE of 17 June 2019, by which, according to the applicant, the Commission would have stopped the authorisation procedure for Listex™ PI 00 and prohibited the placing on the market of Listex™ PI00 as a processing aid. Micreos also made an application for interim measures, which was dismissed as inadmissible by the President of the General Court by Order of 26 September 2019. Nevertheless, this does not mean, as apparently claimed by Micreos that the (President of the) General Court has considered that Listex can be marketed. Paragraph 48 of the Order states that [...Jaccording to the Commission's view, as expressed in the two letters, Listex™ PI 00 falls within the scope of Article 3(2) of Regulation No 853/2004. This implies prima facie that, by virtue of that provision, the qualification as a processing aid for the purpose of decontamination cannot remove the prevailing authorisation obligation under Regulation No 853/2004. Moreover, the President of the General Court clarified in paragraph 49 of his Order that the alleged prohibition on the marketing of Listex™ PI 00 in ready-to-eat foods of animal origin “stems prima facie, directly, from Regulation No 853/2004, as interpreted by the Commission”. Therefore, although the General Court has not issued a judgement on the main application yet, it has not followed at all the applicant’s arguments for interim measures. As already recalled at the meeting on 29 April 2019, there is no authorisation granted for the placing on the market of Listex™ PI 00 in accordance with Article 3(2) of Regulation (EC) No 853/2004 for its use in food of animal origin and there is, in the view of the Commission, no scope for Member States to authorise Listex as processing aid for food of animal origin. I would ask you to send DG SANTE information on the use country and on which product it is used. Yours sincerely,* (i) 2 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives , OJ L 354 31.12.2008, p. 16 . Its Article 3(2)(b) states: "‘processing aid’ shall mean any substance which: (i) is not consumed as a food by itself; (ii) is intentionally used in the processing of raw materials, foods or their ingredients, to fulfil a certain technological purpose during treatment or processing; and (iii) may result in the unintentional but technically unavoidable presence in the final product of residues of the substance or its derivatives provided they do not present any health risk and do not have any technological effect on the final product" 2 Electronically signed on 07/11/2019 16:57 (UTC+01) in accordance with article 4.2 (Validity of electronic documents) of Commission Decision 2004/563 Translation of email of Mr Dirk de Meester, Micreos, to a senior officer of the Ministry of Health, Wellbeing and Sport of The Netherlands, 18 November 2019, in response to a letter of DG SANTE regarding listeria outbreaks/Listex P100 of 8 November 2019: the European Commission has taken no decision, therefore there is nothing to be enforced Many thanks for your mail with appendix dated 13 November 2019. Micreos is also grateful for your statements during the Working Group on Additives meeting in Brussels on Friday 8 November 2019, in which you criticised DG SANTE for the fact that since 2006 the European Commission has not succeeded in setting up an adequate regulatory framework for the use of phages in general and for Listex P100 in particular. Increasing concern has been expressed both in the European Parliament and elsewhere about this delay and about ignoring increasing numbers of victims of listeria outbreaks in many Member States of the European Union. This will lead to far-reaching action. It goes without saying that a commitment by the European Commission in response to a call from the European Parliament to come up with a new regulation on phages and to regard the use of Listex P100 as a ‘non-decontaminating’ processing aid in ready-to-eat foods of animal origin in the meantime, is a (face saving) rescue solution for all parties involved and, above all, for the Listeria victims. The interpretation of your Department's lawyers is in fact an interpretation of the European Commission's interpretation with regard to the application of Article 3(2) of Regulation 853/2004. The EU Court of Justice has explicitly quoted this interpretation of the European Commission, indicating that Micreos has the right to challenge Member States' positions on Listex P100 before a national court if they prevent the marketing of Listex P100 for use as a non-decontaminating process aid. From a legal perspective, it can be added that DG SANTE’s 'interpretation' cannot lead to legal consequences. The fact that this is an interpretation is also evident from the letter from Director- General Anne Bucher dated 17 June 2019 (attachment 1). For a better understanding, the report of the meeting with Mrs Bucher dated 28 June 2019 (attachment 2) is also added. This meeting was attended by the Belgian former Prime Minister Mark Eyskens and a lawyer. A procedure before a national court should lead to a referral to the EU Court for a preliminary ruling that definitively interprets the applicable law in a way that is binding for all. As you know, the Commission has (deliberately or not) only included Article 3(2) of Regulation 853/2004 in its interpretation, whereas Article 2.1(f) of Regulation 852/2004 (i.e. the definition of contamination) in combination with Annex I, Chapter 1 of Regulation 2073/2005 (i.e. the amount of permitted Listeria bacteria in ready- to-eat foods) are also applicable. Our lawyer Spyros Pappas has spoken to Mr. Thévenard of the European Commission. He kindly referred to you to provide us with a copy of the Commission letter of 8 November 2019. As he referred to the acquisition of this letter via the Dutch government, I would ask you to inform the European Commission of our reaction to this letter via the same line, with a copy to all other members of the Working Group. It should be noted that Micreos does not follow the European Commission's interpretation of the Court Order of the EU Court. The arguments put forward by Spyros Pappas for this purpose are set out below: 1. Pursuant to consideration 9 of the Order of 26 September 2019 of the President of the General Court “by letter of 9 May 2019, the applicant requested the Commission to acknowledge the use of Listex™ P100 on animal-derived Ready-To-Eat (RTE)-Food as a non- decontaminating processing aid”. 2. According to consideration 25 of the same Order, Micreos sought “the suspension of operation of an alleged decision by the Commission of 17 June 2019 by which it purportedly prohibited the placing on the EU market of the applicant’s product Listex™ P100 as a non- contaminating processing aid for use on animal-derived RTE-Food”. 3. Consideration 27: “The Commission contends that the present application is inadmissible due to the non-existence of the alleged decision, attacked in the main proceedings”. 4. Indeed, the Commission admits that it has not made a decision prohibiting Listex™ P100 as a non-(de)contaminating processing aid. 5. On the other hand, consideration 45 confirms that “the Commission takes a position as to the question whether the use of Listex™ P100 on animal-derived RTE falls under the scope of Article 3(2) of Regulation No 853/2004 and whether the obligation of an EU authorisation continues to apply for the marketing as a processing aid for the purpose of decontamination of RTE-Food”. 6. To this extent the Order concludes that the position of the Commission is nothing more than “a mere interpretation of the applicable legal framework” (cons. 50), that, if the interpretation of the Commission is right, an authorisation would be required because the use of Listex™ P100 on animal-derived RTE food should be considered as a processing aid which is decontaminating. However, this interpretation remains open until the final Judgment on the Micreos application for annulment in which Micreos, among others, claims that the Commission was wrong in its qualification as a ‘decontaminating processing aid’. Until that moment, the situation ex ante is restored, namely that Listex P100 can keep on being traded as a non-decontaminating processing aid on animal-derived RTE food. The Court Order justifies that Micreos can take Member States to national Court and the latter refer the case to the Court of Justice of the EU if such trading is prohibited. From a scientific point of view this is also correct: Listex™ P100 is only effective and relevant to be applied if the number of bacteria stays under the legally permitted volume. If that legal limit is exceeded the food product is contaminated. If that is not exceeded there is NO contamination and ListexTM P100 is applied in a preventive manner. This is exactly why the Court will have referred to the word ‘non-decontaminating’ processing aid. 7. In view of the above, Micreos informed its stakeholders that, at present, following the Order of the President there is no explicit prohibition of the marketing of the use of Listex™ P100 on animal-derived RTE food. This is corroborated by the fact that the product is on the market since many years now, not to speak about the USA, Canada and Australia where it is formally recognised as a processing aid. Moreover, Micreos expressed its hope that thanks to the pending proceedings the way for natural phages against Listeria is paved. 8. It is with regret that Micreos learned informally about a non-public letter of 8 November 2019 of the Commission to the Chief Veterinary Officers of the Member States; in this letter the Commission turns the established absence of a decision prohibiting the marketing of Listex™ P100 leaving Micreos without judicial protection, into an explicit “Absence of authorisation at EU level of Listex™ P100 for use in food of animal origin” with the view to concluding that, “in the view of the Commission” (hence, another interpretation escaping judicial control), there is “no scope for Member States to authorise Listex as processing aid for food of animal origin”. In this way, without making a challengeable decision and acting beyond its remit, it stimulates Member States to prohibit the marketing of Listex™ P100. In doing so, it omits to clearly remind the positive Scientific Opinion of EFSA and interprets the need of Member States to get guidance in this regard in order to cope with the renewed expansion of Listeria and subsequential listeriosis as being an opposition, leaving thus the EU citizens unprotected. 9. Micreos, despite the damage it is suffering, is not going to further contest this unnecessary comeback of the Commission on the issue since the proceedings before the General Court on the application for annulment are imminent. It would like, however, to point out that whatever the case might be, it is a pity for the Commission as Guardian of the common interest to have stuck to its own interpretation of verbal formalities instead of effectively creating a legal framework in which Listex™ P100 finally does what is needed to prevent that EU citizens who are entitled to optimal protection continue to mourn further losses of human (unborn) lives. As you know Mr Pappas is the former Director General for Consumer Affairs of the European Commission. He knows the processes and procedures within the European Commission which sometimes loses contact with reality and social desirability. In advance I thank you very much for noting our position. Of course, you will be aware of the fact that the rather premature letter of the European Commission once again creates a serious disadvantage for Micreos within the European market. This is contrary to the two priorities of the European Union (support for innovation and SMEs and the requirement to develop alternatives for antibiotics with the highest urgency to combat antibacterial resistance) and to the awarding to Micreos of the highest grant under the HORIZON 2020 program by the same European Commission. Yours Sincerely, Dirk de Meester Director Business Development Micreos Food Safety Saatja: Karen Meesen <[email protected]> Saadetud: 21.11.2019 18:25 Adressaat: SM Info <[email protected]> Teema: FW: Letter for H.E. the Minister of Health Manused: 1. 2019-11-18 Open Letter Micreos to MEPs.pdf; 2. 2019-11-18 English translation Micreos letter to Dutch Ministry of Health.pdf; 3. 2019-11-08 Letter of DG Sante Director Bernard Van Goethem re absence of authorization Listex on food of animal origin.pdf; Estonia.pdf To the office of H.E. Riina Sikkut Dear Madam, dear Sir, On behalf of Prof. Mark Eyskens, former Prime Minister of Belgium, may I kindly request you to present his letter, regarding the prevention of further listeria victims in Europe, to H.E. the Minister, together with its attachments. We are very grateful for your assistance. Yours sincerely, Karen Meesen PA International Foundation Franklinstraat 106-108, 1000 Brussels, Belgium Tel: (+32)(0)2 735 83 96, Fax: (+32)(0)2 735 84 66 Email: [email protected] www.pa-international.org Disclaimer 1. This e-mail is for the intended recipient only. If you have received it by mistake please let us know by reply and then delete it from your system; access, disclosure, copying, distribution or reliance on any of it by anyone else is prohibited. 2. If you as intended recipient have received this e-mail incorrectly, please notify the sender (via e-mail) immediately. This e-mail is confidential and may be legally privileged. PA International does not guarantee that the information sent and/or received by or with this e-mail is correct and does not accept any liability for damages related thereto. H.E. Riina Sikkut Minister of Health and Labour of Estonia By email: [email protected] Brussels, 21 November 2019 Ref. nr.: 19.38900 Your Excellency, It has been particularly moving to be informed about the loss of unborn life as a consequence of listeria outbreaks in Spain, Germany and the Netherlands in the past two months. Around 1,000 European citizens died, were maimed or suffered other consequences of food poisoning by the most lethal foodborne pathogen listeria bacteria. As a former Prime Minister, I understand the burden of correctly applying laws and regulations while ultimately prioritizing the protection of human lives. In the case of recurrent, increasingly frequent and lethal outbreaks of listeria European society has reached a point that technical debates no longer serve European citizens’ public health. The best of scientists including the European Food Safety Authority have established that the phage Listex P100 is totally safe and effective. This product is used legally and correctly in all major global markets but in the EU the lack of a phage regulation has seduced DG SANTE to try to regulate the use of Listex P100 on animal-derived Ready-To-Eat food in an evidently less fitting regulatory environment. It should be understood also by DG SANTE that a specific phage regulation has many benefits including that such regulation only applies to phages. Key Members of the European Parliament of all major Groups therefore already called on the European Commission to create a specific phage regulation and to consider the use of Listex P100 a processing aid for use on animal-derived food. According to the European Commission itself, phages may have a decisive role to play in combating Antimicrobial Resistance and several other potentially lethal infections. Therefore, this month DG RTD awarded the highest possible grant under the Horizon 2020 program to the Dutch SME Micreos for its innovative and effective investment in the development and production of new life-saving phage-derived products. Obviously, this reflects the European Union’s policy to strongly support both innovation and SME development. I regret to say that DG SANTE apparently does not: please refer to the attached letter of Micreos CEO Mr Mark Offerhaus to all Members of the European Parliament. I wholeheartedly support this letter and also the attached letter by Micreos to the Dutch authorities which kindly provided Micreos with a non-public letter in which DG SANTE tries to convince the Chief Veterinary Officers of the EU Member States to take action against Listex P100 even though DG SANTE maintains vis-à-vis the European Union Court of Justice that it has taken no decision on the regulatory position of Listex P100. I support the legal analysis of Micreos’ lawyer and former Director General for Consumer Affairs of the European Commission Mr Spyros Pappas, that ‘interpretations’ of the European Commission cannot lead to any form of enforcement in law – unless the European Commission is both regulator and judge. Thank you very much in advance for helping to ensure that the European institutions protect our health and human lives, also in order to convince Generation Z that the European Commission is there for them. Yours sincerely, Prof. Mark Eyskens Chairman, PA International Foundation Minister of State and former Prime Minister of Belgium Attachments: - Open Letter of Mark Offerhaus, CEO of Micreos, to all Members of the European Parliament, 18 November 2019 - Mail of Dirk de Meester, Director Business Development of Micreos, to the Dutch Ministry of Health, 18 November 2019 (English translation) - Letter of DG SANTE to the Chief Veterinary Officers of the EU Member States, 8 November 2019
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel